Eton Pharmaceuticals, INC. (ETON) SEC Filings — 2025

Filings

• Eton Pharmaceuticals, INC. 8-K Filing — 8-K · Dec 4, 2025
• Eton Pharmaceuticals Files 8-K/A for Asset Acquisition — 8-K/A · Nov 18, 2025
• Eton Pharma's Revenue Soars 114%, But Net Loss Widens to $6.08M — 10-Q · Nov 6, 2025
• Eton Pharma Sees Revenue Surge in Q2 2025 on Product Sales — 10-Q · Aug 7, 2025
• Eton Pharmaceuticals Files 8-K — 8-K · Jul 8, 2025
• Eton Pharmaceuticals Files 8-K — 8-K · Jun 27, 2025
• Eton Pharmaceuticals Changes Auditors — 8-K · Jun 20, 2025
• Eton Pharmaceuticals Files 8-K on Shareholder Votes — 8-K · Jun 10, 2025
• Eton Pharmaceuticals Files 8-K — 8-K · May 28, 2025
• Eton Pharmaceuticals Files 8-K on Financials — 8-K · May 13, 2025
• Eton Pharmaceuticals Files 8-K/A for Increlex Update — 8-K/A · May 2, 2025
• Eton Pharmaceuticals Files 8-K — 8-K · Apr 28, 2025
• Eton Pharmaceuticals Files Annual Proxy Statement — DEF 14A · Apr 25, 2025
• Eton Pharmaceuticals Files 8-K for Financials and Exhibits — 8-K · Apr 1, 2025
• Eton Pharmaceuticals Files 2024 10-K — 10-K · Mar 18, 2025
• Eton Pharmaceuticals Files 8-K — 8-K · Mar 14, 2025
• Eton Pharma Amends 8-K for Increlex Deal — 8-K/A · Mar 7, 2025
• Eton Pharmaceuticals Files 8-K — 8-K · Mar 3, 2025
• Eton Pharmaceuticals Files 8-K — 8-K · Feb 7, 2025
• Eton Pharmaceuticals Files 8-K — 8-K · Feb 6, 2025
• Eton Pharmaceuticals Completes 03 Life Sciences Acquisition — 8-K · Jan 3, 2025